SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-039955
Filing Date
2021-10-12
Accepted
2021-10-12 20:18:56
Documents
2
Period of Report
2021-10-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1644
2 EX-24 DOCUMENT attachment1.htm EX-24 4183
  Complete submission text file 0000899243-21-039955.txt   7186
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GALERA THERAPEUTICS, INC. 2 W LIBERTY BOULEVARD, #110 MALVERN PA 19355
Business Address
Bachleda Mark (Reporting) CIK: 0001887762 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39114 | Film No.: 211319870